Home > Instruments & Tests > Lab tests

Lab tests

Gene expression array for uveal melanoma


Castle Biosciences has launched a new assay for uveal melanoma. This proprietary gene expression assay,
called DecisionDx-UM was discovered at Washington University in St Louis. This enables prospective identification of patients who have a low risk (Class 1 molecular signature) or high risk (Class 2 molecular signature) of developing metastatic disease. Development and validation of the assay in our CLIA-certified laboratory is complete and it is now available for clinical use.